Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5873974 | 1.00 | FAAH (0.46) | FAAHTRPV1LPAR3LPAR1LPAR2 | |
| SCHEMBL9869504 | 0.98 | FAAH (0.50) | FAAHTRPV1LPAR3LPAR1LPAR2 | |
| SCHEMBL9869502 | 0.98 | FAAH (0.50) | FAAHTRPV1LPAR3LPAR1LPAR2 | |
| SCHEMBL27512003 | 0.95 | LPAR1 (0.48) | FAAHTRPV1LPAR3LPAR1LPAR2 | |
| SCHEMBL26753904 | 0.93 | LPAR1 (0.52) | FAAHTRPV1LPAR3LPAR1LPAR2 | |
| SCHEMBL27445901 | 0.93 | LPAR1 (0.52) | FAAHTRPV1LPAR3LPAR1LPAR2 | |
| SCHEMBL6691272 | 0.89 | FAAH (0.50) | FAAHTRPV1LPAR3LPAR1LPAR2 | |
| SCHEMBL5520439 | 0.88 | FAAH (0.52) | FAAHTRPV1LPAR3 | |
| SCHEMBL5520469 | 0.88 | TSHR (0.48) | — | |
| SCHEMBL5520472 | 0.88 | TSHR (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030286-B2 | Reacting 1,3-butadiene with a telogen such as methanol, using a telomerization catalyst to form a telomer, partially hydrogenating the telomer to form a 1-substituted 2-octene and dissociating it to give 1-octene | OXENO OLEFINCHEMIE GMBH (DE) | 2006-04-18 | — | — | US | disclosed |
| CN-1219738-C | Method for producing 1-octen | OXENO OLEFINCHEMIE GMBH (DE) | 2005-09-21 | — | — | CN | disclosed |
| EP-1358140-B1 | METHOD FOR PRODUCING 1-OCTEN | OXENO OLEFINCHEMIE GMBH (DE) | 2004-12-29 | — | — | EP | disclosed |
| CN-1491195-A | Method for producing 1-octen | �¿�ɭŵ���շһ�ѧ�ɷ�����˾ | 2004-04-21 | — | — | CN | disclosed |
| US-20040059170-A1 | Method for producing 1-octen | OXENO OLEFINCHEMIE GMBH (DE) | 2004-03-25 | — | — | US | disclosed |
| EP-1358140-A1 | METHOD FOR PRODUCING 1-OCTEN | Oxeno Olefinchemie GmbH (DE) | 2003-11-05 | — | — | EP | disclosed |
| WO-2002062732-A1 | METHOD FOR PRODUCING 1-OCTEN | OXENO OLEFINCHEMIE GMBH (DE) | 2002-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059170-A1 | Method for producing 1-octen | TELO2, DOHH, TPH2 | FAAH 135/4885TRPV1 3407/4885LPAR3 3337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.